These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 3344851)

  • 21. Cerebrotendinous xanthomatosis.
    Berginer VM; Salen G; Shefer S
    Neurol Clin; 1989 Feb; 7(1):55-74. PubMed ID: 2493565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cerebrotendinous xanthomatosis: report of one case].
    Filippi J; Irarrázaval S; Peredo P; Mellado P
    Rev Med Chil; 2009 Jun; 137(6):815-20. PubMed ID: 19746285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
    Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S
    N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco-Sjoegren syndrome: a case report.
    Siebner HR; Berndt S; Conrad B
    J Neurol Neurosurg Psychiatry; 1996 May; 60(5):582-5. PubMed ID: 8778269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress.
    Gonzalez-Cuyar LF; Hunter B; Harris PL; Perry G; Smith MA; Castellani RJ
    Redox Rep; 2007; 12(3):119-24. PubMed ID: 17623518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cerebrotendinous xanthomatosis].
    Burghaus L; Liu W; Haupt WF
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1463-6. PubMed ID: 17583829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.
    DeBarber AE; Schaefer EJ; Do J; Ray JW; Larson A; Redder S; Fowler M; Duell PB
    J Clin Lipidol; 2024; 18(3):e465-e476. PubMed ID: 38637260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrotendinous xanthomatosis (a rare lipid storage disorder): a case report.
    Razi SM; Gupta AK; Gupta DC; Gutch M; Gupta KK; Usman SI
    J Med Case Rep; 2016 Apr; 10(1):103. PubMed ID: 27094915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism.
    Salen G
    Ann Intern Med; 1971 Dec; 75(6):843-51. PubMed ID: 5134895
    [No Abstract]   [Full Text] [Related]  

  • 30. Cerebrotendinous xanthomatosis in three siblings from a Chinese family.
    Ko KF; Lee KW
    Singapore Med J; 2001 Jan; 42(1):30-2. PubMed ID: 11361235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid in three siblings.
    Chang WN; Kuriyama M; Chee EC
    J Formos Med Assoc; 1994 Mar; 93(3):256-9. PubMed ID: 7920069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.
    Nie S; Chen G; Cao X; Zhang Y
    Orphanet J Rare Dis; 2014 Nov; 9():179. PubMed ID: 25424010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical report: A patient with a late diagnosis of cerebrotendinous xanthomatosis and a response to treatment.
    Alhariri A; Hamilton K; Oza V; Cordoro K; Sobreira NL; Malloy M; Slavotinek A
    Am J Med Genet A; 2017 Aug; 173(8):2275-2279. PubMed ID: 28590052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
    Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A
    J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid.
    Björkhem I; Skrede S; Buchmann MS; East C; Grundy S
    Hepatology; 1987; 7(2):266-71. PubMed ID: 3557306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of cerebrotendinous xanthomatosis: effects of ursodeoxycholic acid administration on serum bile acids and cholestanol.
    Kimura S; Beppu T; Kugai N; Koide Y; Fujita T; Iida K; Yamashita N; Yamashita K; Seyama Y
    Jpn J Med; 1982 Jul; 21(3):210-5. PubMed ID: 7143816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
    Siman-Tov T; Meiner V; Gadoth N
    J Neurol Sci; 2006 Apr; 243(1-2):83-6. PubMed ID: 16445943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).
    Salen G; Steiner RD
    J Inherit Metab Dis; 2017 Nov; 40(6):771-781. PubMed ID: 28980151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cerebrotendinous xanthomatosis: report of 4 patients].
    Ferrándiz-Pulido C; Bartralot R; Girós M; Bassas P; Heras C; Bodet D; Savall R; García-Patos V
    Actas Dermosifiliogr; 2009 Apr; 100(3):222-6. PubMed ID: 19457308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis.
    Verrips A; van Engelen BG; Wevers RA; van Geel BM; Cruysberg JR; van den Heuvel LP; Keyser A; Gabreëls FJ
    Arch Neurol; 2000 Apr; 57(4):520-4. PubMed ID: 10768627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.